차백신연구소, 40억원 규모 전환사채 발행...운영자금 조달

Cha Vaccine Research Institute is securing 4 billion KRW through convertible bonds to stabilize its financial liquidity and accelerate critical R&D activities. This strategic funding reflects the biotech industry's trend of utilizing private capital to sustain long-term clinical development cycles amidst challenging market conditions.